Quick Heal Technologies Ltd Q2FY26 FY26 – When Antivirus Catches a Virus: Margins -95%, CEO Gone, Stock Crawling at ₹327
1. At a Glance
Quick Heal Technologies Ltd — the once-glorious antivirus wallah of your Windows XP era — is now battling its own malware: declining margins, evaporating profits, and a CEO who rage-quit faster than you can say “update definitions.”
At ₹327 per share (as of Oct 21, 2025), the company’s market cap stands at ₹1,771 crore. Stock’s down nearly 51% YoY, as if the market just hit “clean quarantine folder.” Three-month return? A modest –2.39%, because apparently, hope too needs an antivirus.
Revenue this quarter (Q2FY26) came in at ₹83.5 crore, up 13.6% QoQ, while PAT rose 90% to ₹7.9 crore — but let’s not celebrate too early. FY24 margins barely touched 6%, down from 31% two years ago. ROE sits at 0.63%, ROCE is actually negative, and debt is zero because lenders ghosted them before the virus did.
Basically, the once-mighty cybersecurity champ is now patching its own software — and reputation.
2. Introduction
Once upon a time, every desi PC owner had two rituals: downloading movies from torrents and running Quick Heal after. It was the OG “security subscription” before Netflix made us pay for buffering.
Fast-forward to FY26: the company that kept viruses away is now infected with shrinking consumer demand, ballooning R&D spend, and management exits. The founder tried to pivot from “Antivirus CD in Nehru Place” to “AI-based Zero-Trust Enterprise Solutions” — but Wall Street still hears “Please Install Update.”
Its consumer vertical (still 63% of revenue) is coughing up sales like a Windows Vista update. Meanwhile, the enterprise brand Seqrite is doing the heavy lifting, growing its share to 37% and roping in big names like NFSU and IIM Nagpur for cyber-research. Noble move, but investors seem more interested in antivirus for their portfolios.
The irony? Quick Heal just joined the U.S. Artificial Intelligence Safety Consortium — maybe they’ll finally use AI to detect their own falling EPS.
3. Business Model – WTF Do They Even Do?
Quick Heal Technologies sells cybersecurity software — think of it as digital hand sanitizer for your laptop. Its business is split between:
Consumer Security (63%) — Anti-virus, anti-malware, anti-everything except anti-loss. Sold under the iconic “Quick Heal” brand through a network of 35,000 dealers and 300+ distributors across 22 cities.
Enterprise & Government Security (37%) — Operates under the Seqrite brand, offering endpoint protection, data classification, threat response, and now AI-based fraud prevention tools like AntiFraud.AI.
The consumer side is dying of old age — people don’t install antivirus anymore; they install Chrome extensions. The enterprise side is finally catching momentum, landing orders from the National Forensic Science University (₹18 crore) and partnerships with M.Tech Solutions and the U.S. NIST Cybersecurity Center.
But there’s a twist. R&D spending has exploded — from ₹91 crore (26% of revenue) in FY22 to ₹133 crore (46%) in FY24. Imagine spending half your income on a gym membership but still gaining weight. That’s Quick Heal’s margin story.
4. Financials Overview
Metric
Latest Qtr (Q2FY26)
YoY Qtr (Q2FY25)
Prev Qtr (Q1FY26)
YoY %
QoQ %
Revenue
₹83.52 Cr
₹73.49 Cr
₹57.23 Cr
13.6%
45.9%
EBITDA
₹9.23 Cr
₹3.07 Cr
₹–9.73 Cr
200.6%
NA
PAT
₹7.91 Cr
₹4.15 Cr
₹–5.51 Cr
90.6%
NA
EPS (₹)
1.46
0.77
–1.02
89.6%
NA
Annualised EPS = ₹1.46 × 4 = ₹5.84 At CMP ₹327, P/E ≈ 56x — yes, fifty-six times last quarter’s optimism.
👉 Witty take: The antivirus maker seems to be infected by “multiple compression.”
5. Valuation Discussion – Fair Value Range
Let’s not “target” anything, let’s just do math like adults.
Method 1: P/E Approach Industry median P/E ≈ 35.8 EPS (annualised) = ₹5.84 Fair Value = 5.84 × (30 to 40) = ₹175 – ₹234
Method 2: EV/EBITDA Approach EBITDA (annualised) ≈ ₹9.23 × 4 = ₹36.9 Cr Enterprise Value = ₹1,750 Cr → EV/EBITDA ≈ 47x Peer median ≈ 20–25x → Fair EV ≈ ₹740 – ₹925 Cr → Equity value ≈ ₹137 – ₹170 per share
Method 3: DCF (Discounted Comedy Flow) Assuming 10% revenue CAGR, 12% EBITDA margin by FY28, and 10% WACC → fair value ~₹190–₹230
🎯 Fair Value Range (Educational): ₹170 – ₹230 per share (This fair value range is for educational purposes only and not investment advice.)
6. What’s Cooking – News, Triggers, Drama
If Quick Heal were a Bollywood plot, Q2FY26 would be the part where the hero loses his job, gets dumped, but still shows up with a fake smile.
Oct 15 2025: Q2 results out — revenue ₹83.5 Cr, PAT ₹7.9 Cr. Investors yawned.
Sep 4 2025: CEO Vishal Salvi resigned “to pursue alternative
